Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

hDectin-1 is involved in uptake and cross-presentation of cellular antigens.

Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Grünebach F, Brossart P.

Blood. 2008 Apr 15;111(8):4264-72. Epub 2007 Aug 13.

2.

TLR ligands differentially affect uptake and presentation of cellular antigens.

Weck MM, Grünebach F, Werth D, Sinzger C, Bringmann A, Brossart P.

Blood. 2007 May 1;109(9):3890-4. Epub 2007 Jan 11.

3.

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljeström P, Reis e Sousa C.

Nature. 2005 Feb 24;433(7028):887-92. Epub 2005 Feb 13.

4.

Immunomodulatory effects of beta-glucans on porcine alveolar macrophages and bone marrow haematopoietic cell-derived dendritic cells.

Chaung HC, Huang TC, Yu JH, Wu ML, Chung WB.

Vet Immunol Immunopathol. 2009 Oct 15;131(3-4):147-57. doi: 10.1016/j.vetimm.2009.04.004. Epub 2009 Apr 11.

PMID:
19410299
5.

Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway.

Xie J, Zhu H, Guo L, Ruan Y, Wang L, Sun L, Zhou L, Wu W, Yun X, Shen A, Gu J.

J Immunol. 2010 Aug 15;185(4):2306-13. doi: 10.4049/jimmunol.0903214. Epub 2010 Jul 14.

6.

Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.

Brusa D, Garetto S, Chiorino G, Scatolini M, Migliore E, Camussi G, Matera L.

Vaccine. 2008 Nov 25;26(50):6422-32. doi: 10.1016/j.vaccine.2008.08.063. Epub 2008 Oct 9.

PMID:
18848858
7.

Viral immunity: cross-priming with the help of TLR3.

Salio M, Cerundolo V.

Curr Biol. 2005 May 10;15(9):R336-9. Review.

8.

Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.

Klotz L, Hucke S, Thimm D, Classen S, Gaarz A, Schultze J, Edenhofer F, Kurts C, Klockgether T, Limmer A, Knolle P, Burgdorf S.

J Immunol. 2009 Jul 1;183(1):129-36. doi: 10.4049/jimmunol.0804260. Epub 2009 Jun 17.

9.

Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells.

Susumu S, Nagata Y, Ito S, Matsuo M, Valmori D, Yui K, Udono H, Kanematsu T.

Cancer Sci. 2008 Jan;99(1):107-12. Epub 2007 Nov 7.

10.

ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.

Schnurr M, Orban M, Robson NC, Shin A, Braley H, Airey D, Cebon J, Maraskovsky E, Endres S.

J Immunol. 2009 Feb 1;182(3):1253-9. Erratum in: J Immunol. 2009 Apr 15;182(8):5152.

11.

Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

Jirmo AC, Nagel CH, Bohnen C, Sodeik B, Behrens GM.

J Immunol. 2009 Jan 1;182(1):283-92.

12.

The role of Dectin-1 in antifungal immunity.

Herre J, Willment JA, Gordon S, Brown GD.

Crit Rev Immunol. 2004;24(3):193-203. Review.

PMID:
15482254
13.

Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae.

Wadle A, Held G, Neumann F, Kleber S, Wuellner B, Asemissen AM, Kubuschok B, Scheibenbogen C, Breinig T, Meyerhans A, Renner C.

Vaccine. 2006 Sep 11;24(37-39):6272-81. Epub 2006 Jun 14.

PMID:
16860448
14.

Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies.

Signorino E, Brusa D, Granata R, Malavasi F, Ferrone S, Matera L.

Cancer Biol Ther. 2007 Dec;6(12):1932-7. Epub 2007 Sep 3.

PMID:
18087220
15.

Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses.

Ni L, Gayet I, Zurawski S, Duluc D, Flamar AL, Li XH, O'Bar A, Clayton S, Palucka AK, Zurawski G, Banchereau J, Oh S.

J Immunol. 2010 Sep 15;185(6):3504-13. doi: 10.4049/jimmunol.1000999. Epub 2010 Aug 20.

16.

Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.

Bleifuss E, Bendz H, Sirch B, Thompson S, Brandl A, Milani V, Graner MW, Drexler I, Kuppner M, Katsanis E, Noessner E, Issels RD.

Int J Hyperthermia. 2008 Dec;24(8):623-37. doi: 10.1080/02656730802213384.

PMID:
18608582
17.

Assessing vaccine potency using TCRmimic antibodies.

Neethling FA, Ramakrishna V, Keler T, Buchli R, Woodburn T, Weidanz JA.

Vaccine. 2008 Jun 13;26(25):3092-102. doi: 10.1016/j.vaccine.2008.02.025. Epub 2008 Feb 25.

PMID:
18353510
18.

The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells.

Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S, Brown GD.

Eur J Immunol. 2005 May;35(5):1539-47.

19.

Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC.

Chen L, Fredholm BB, Jondal M.

Mol Immunol. 2008 Apr;45(8):2247-54. doi: 10.1016/j.molimm.2007.11.016. Epub 2008 Feb 21.

PMID:
18178251
20.

Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes.

Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y.

Br J Dermatol. 2009 Feb;160(2):297-304. doi: 10.1111/j.1365-2133.2008.08897.x. Epub 2008 Oct 21.

PMID:
19016710

Supplemental Content

Support Center